Streetbeat News

Acquisitions Mergers

KTRA

Kintara Therapeutics has announced the record date for Contingent Value Rights issuance related to its merger with TuHURA Biosciences, expected to close on October 18, 2024. The merger will make TuHURA a wholly-owned subsidiary of Kintara.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:34 pm

RILY

B. Riley Financial has agreed to sell its Appraisal and Valuations unit, Great American, to Oaktree Capital for $386 million. The deal involves a new holding company, Great American NewCo, with B. Riley receiving cash and equity, and Oaktree acquiring a majority stake. The transaction is expected to close in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:30 pm

BLCO

Bausch + Lomb shares are trading higher due to a report that TPG and Blackstone are collaborating on a joint bid.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:30 pm

BLCO

TPG and Blackstone are collaborating to bid for Bausch + Lomb, a significant player in the eye health industry. This move could impact Bausch + Lomb's market position and valuation.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:29 pm

VNDA

Vanda Pharmaceuticals shares are trading higher following Cycle Pharmaceuticals' reaffirmation of its proposal to acquire the company for $8.00 per share in cash.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:21 pm

VNDA

Cycle Pharmaceuticals has reaffirmed its proposal to acquire Vanda Pharmaceuticals for $8.00 per share in cash.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:20 pm

AMRK

A-Mark Precious Metals' subsidiary, Silver Towne Mint, has acquired the assets of Regency Mint Manufacturing for $2 million. This acquisition includes minting equipment and a customer list, enhancing Silver Towne Mint's production capabilities.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:20 pm

VCTR

Victory Capital Holdings, Inc. (NASDAQ:VCTR) announced that its shareholders approved all proposals related to a contribution agreement with Amundi. The company reaffirms its guidance of $100 million in expense synergies, expected to be realized within two years, with the majority in the first year. The transaction is anticipated to close in Q1 2025, pending regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:08 pm

HOLX

Hologic has announced its acquisition of Gynesonics, a women's health medical device company, for approximately $350 million. This move is expected to enhance Hologic's portfolio in the women's health sector.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:05 pm

LBPH

Longboard Pharmaceuticals shares are trading higher following the announcement of its acquisition by Lundbeck.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 11:40 am